February 2021

EIT Health Germany Newsletter 

Dear EIT Health Partners and Friends,

The first weeks of 2021 have already passed and I hope you all got off to a safe and successful start to the new year. This month's newsletter has a lot of exciting opportunities in store for you, so please do read on!

I am particularly happy to announce that the EIT Health Germany flagship programme Start-Ups Meet Pharma 2021 is officially open for applications. In 2021, five pharma companies: Takeda, Abbot, Merck, Amgen and AstraZeneca will open their innovation departments and explore collaborations with start-ups through the SMP2021 programme. Past editions of the programme have proven to be very beneficial to former participants with many NDAs signed, clinical trials kicked-off and collaborative projects in the works.  Read on further below to find out more about just how successful the programme was and how to become involved.

Enjoy the read! 

Dr. Katharina Ladewig
Managing Director EIT Health Germany


Monthly Focus - Applications now open for Start-Ups Meet Pharma 2021

Hey healthcare innovators, are you ready for a challenge? Are you working in the field of Chronic Kidney Disease? Or maybe Multiple Sclerosis? Or maybe your solution helps with the diagnosis of Adult ADHD? If you answered with 'yes' on any or all these questions, then we have a great opportunity for you. 

We are delighted to announce the opening of the call for applications for Start-ups Meet Pharma 2021. This challenge-based acceleration programme connects key pharma partners in Europe with startups at the forefront of technological innovation. In 2021, we have partnered with five Pharma companies, Takeda, Abbot, Merck, Amgen and AstraZeneca as our challenge-providers, and we now invite start-ups to address the set challenges with their products and services. Deadline: 16 March 2021.

Further information about the programme and the 2021 challenges can be found here

What's coming up? 
The EIT Health Accelerator Catalogue 2021 is out!

We invite entrepreneurs, start-ups and SMEs to submit applications to our programmes and accelerate their growth. Whether you need access to knowledge, new markets, key stakeholders, or investors and funding – EIT Health can help.
More info
New Start-up Ecosystem Platform launched! 

EIT Health has partnered with Dealroom to create a dedicated EIT Health Start-up platform, enabling users to track the latest developments of our start-ups within the ecosystem and making the EIT Health pipeline transparent and visible. 

More info
VCoE and EIF launch call for VCs to join

Venture capital funds interested in healthcare innovations can now apply to cooperate with the Venture Centre of Excellence (VCoE) through the Call for Expressions of Interest published by the European Investment Fund (EIF). 
More info

News from the community

Big success for 24-hour care: DIN Standard for exemplary home care published 

Congratulations to Mecasa, our 2019 Headstart Programme finalist, for successfully initiating the first DIN Standard for qualitative 24h care. DIN SPEC 33454 sets an important impulse for legal and social balance and is intended to provide standardised protection for customers and caregivers alike. For the first time, the strict requirements of the new quality standard differentiate between nurse-provided care and unqualified personnel placement. The new quality standard is not Mecasa’s only project in exemplary home care. Their digital placement platform with a psychological matching model has reduced the dropout rate of caregiver relationships from 31 to 12 percent.

Read the complete story here

Medical Magnesium ready for EU market entry

RWTH Aachen University's spin-off and EIT Health Catapult finalist Medical Magnesium is ready for EU market entry thanks to their recent achievement of the CE Mark being granted to their resorbable implant systems based on mm.X technology. Medical magnesium's metallic bioabsorbable implants for orthopedic and trauma surgery are made of magnesium. The implants are mechanically stable and physiologically degradable after fracture healing, leading to a minimal amount of intervention and effective innovative patient care. “Our vision is to enable surgeons to improve patient care through our highly functional resorbable mm.X implants. Our first market approvals now open up exactly this path and more implants […] are already in development,” states Kilian Reuß, CEO and Co-founder. 

Find out more.

News closer to home 

Manfred Heinzer joins EIT Health Germany Supervisory Board

A warm welcome to Manfred Heinzer, Vice President and General Manager of Amgen Germany, as a new member of the EIT Health Germany Supervisory Board, representing the DACH region within EIT Health's 150+ member strong, pan-European network. 

Curious to see the faces behind EIT Health Germany? Click here for more information on our Supervisory Board members (German only).

We look forward to our continued work together in 2021! 

Making cancer history with Miltenyi Biotec

On the occasion of World Cancer Day, we talked to Martha Elia Luevano Salinas, an expert for CAR-T cell engineering and application at Miltenyi Biotec, on the latest developments at the frontier of cancer research. Since 1989 our partner Miltenyi Biotec is striving to make a difference for patients who fight cancer every day. Learn more about how Miltenyi Biotec's researchers combine deep biologic knowledge with cutting-edge research technology to identify transformational improvements in the care of cancer patients.

Full interview here.

What we are reading

The COVID-19 pandemic has influenced health systems around the world to shift further towards digitalization, but how can that shift be carried out successfully? A “Digitalizing healthcare” paper by Siemens Healthineers provides good examples of how to build a digital enterprise that is successful and sustainable. Read the paper here
Interest and investment in European healthtech are booming, but what will 2021 bring? Three European investors answer the question and reveal five trends in digital health to look out for. Read the Sifted article here.

Events and Opportunities

16 February 2021Accelerator Catalogue 2021 webinar series (On-going) 

17 February 2021 - heiINNOVATION talks - 
Digital solutions and services for the healthcare industry - Prof. (apl.) Dr. Daniel Gotthard – Gotthardt Healthgroup AG Heidelberg

20 February 2021 - Deadline for applications for M1 | Essential Skills for Innovative Healthcare (Transformative Digital Skills for Healthcare course)

20 February 2021 - Deadline for applications for M2 | Leading the Healthcare Transformation ((Transformative Digital Skills for Healthcare course)

23 February 2021Bi-weekly webinars on EIT Health Call  BP2022 (On-going) 

24 February 2021 (11.00 CET) - Start-ups Meet Pharma 2021 webinar (Register here)

3 March 2021 (11:00 CET) - Bridgehead 2021 webinar (Register here)

9 March 2021 (12.00 CET) - Start-ups Meet Pharma 2021 webinar (Register here)

10 March 2021 (10:00 CET) - EIT Health Catapult 2021 webinar (Register here

16 March 2021 - Deadline for applications for Wild Card programme

16 March 2021 - Deadline for applications for Women Entrepreneurship Bootcamp

Let's stay in touch

If you like our newsletter, feel free to forward it to anyone else who might like it too.
Website Website
LinkedIn LinkedIn
Twitter Twitter
YouTube YouTube

This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
EIT Health Germany · Sandhofer Str. 116 · Mannheim 68305 · Germany